Hazlett, Burt & Watson’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$934K Sell
2,157
-4
-0.2% -$1.21K 0.25% 108
2026
Q1
$461K Sell
2,161
-49
-2% -$11K 0.14% 150
2025
Q4
$379K Sell
2,210
-24
-1% -$3.73K 0.12% 166
2025
Q3
$297K Buy
2,234
+1,066
+91% +$113K 0.1% 176
2025
Q2
$114K Buy
1,168
+648
+125% +$51.4K 0.05% 265
2025
Q1
$37K Hold
520
0.02% 393
2024
Q4
$37K Sell
520
-20
-4% -$1.52K 0.02% 392
2024
Q3
$44K Buy
540
+430
+391% +$37.4K 0.02% 366
2024
Q2
$12K Hold
110
0.01% 511
2024
Q1
$11K Buy
+110
New +$9.68K 0.01% 508

Other funds holding LRCX

Hazlett, Burt & Watson's LRCX Position: Q2 2026 in Review

Hazlett, Burt & Watson reduced its Lam Research (LRCX) stake by 0.19% in Q2 2026, selling an estimated $1.21K and leaving 2,157 shares worth $934K. The position accounts for 0.25% of the portfolio, ranked #108.

Hazlett, Burt & Watson first reported a position in LRCX in Q1 2024 and has held it in 10 quarters since. 3,135 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Hazlett, Burt & Watson held 2,157 shares of Lam Research worth $934K as of Q2 2026.
  • Hazlett, Burt & Watson sold 4 Lam Research shares in Q2 2026, an estimated $1.21K.
  • Lam Research made up 0.25% of Hazlett, Burt & Watson's portfolio in Q2 2026, its #108 holding.
  • Hazlett, Burt & Watson first reported a position in Lam Research in Q1 2024 and has held it in 10 quarters since.
  • 3,135 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q2 2026, filed 30 Jul 2026.